康龙化成（北京）新药技术股份有限公司
企业 · 北京市, China · LEI 300300JYXHGVS5SNGG54
LEI activegroup parent
Summary
康龙化成（北京）新药技术股份有限公司 is registered in China and entered in the “National Enterprise Credit Information Publicity System” under number 9111030276350109XG. Its legal form is 企业 – enterprise (China). 康龙化成（北京）新药技术股份有限公司 is the ultimate parent of a group of 1 subsidiary in 2 countries, as reported to GLEIF. GLEIF gives this reason: no known person controls the entity, for example because its shareholders are diverse. It has 1 direct subsidiary in GLEIF data; 1 of them has a lapsed LEI. The LEI was first issued on 19 Dec 2019 and the record was last updated on 17 Sep 2026; the next renewal is due by 15 Nov 2027.
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
No data-quality notes for this entity in this data release.
Company details
| Legal form | 企业 enterprise (China) |
|---|---|
| Register | National Enterprise Credit Information Publicity System · Register website |
| Registration number | 9111030276350109XG |
| Registration authority | State Administration for Market Regulation |
| Jurisdiction | China |
| Registered address | 泰河路6号1幢八层, 经济技术开发区, 100176 北京市, China |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 1 Jul 2004 |
| LEI | 300300JYXHGVS5SNGG54 |
| LEI status | active |
| LEI first issued | 19 Dec 2019 |
| LEI record last updated | 17 Sep 2026 |
| Next LEI renewal | 15 Nov 2027 |
| Corroboration of the LEI record | fully corroborated |
Group membership
康龙化成（北京）新药技术股份有限公司 this entity
Parent not reported to GLEIF
- Direct parent: no known person controls the entity, for example because its shareholders are diverse.
- Ultimate parent: no known person controls the entity, for example because its shareholders are diverse.
Direct subsidiaries (1)
- Pharmaron (Hong Kong) International Limited Hong Kong lapsed · Hong Kong